首页> 外文会议>International Conference on Mechatronics, Materials, Chemistry and Computer Engineering >Study on the Expression of Osteopontin Coding Gene in Ovarian Cancer
【24h】

Study on the Expression of Osteopontin Coding Gene in Ovarian Cancer

机译:卵巢癌中骨桥蛋白编码基因表达的研究

获取原文

摘要

Osteopontin (OPN), as a malignant transformation related protein phosphorylation was firstly completed the extraction by Senger in 1979. With the progress of research on osteopontin (OPN), people found out that there was little amount in the normal tissues that was showed with low expression, however, in a variety of malignant tumors, the amount of OPN was over expressed. In this paper, it takes the structure and function of osteopontin as the breakthrough point, exploring the expression and the function of osteopontin (OPN) in ovarian cancer.
机译:作为恶性转化相关蛋白质磷酸化的骨偶联蛋白(OPN)首先在1979年完成了Senger的提取。随着对骨桥蛋白(OPN)的研究进展,人们发现较低的正常组织中存在很少的量然而,表达在各种恶性肿瘤中,OPN的量被表达。本文中,骨桥蛋白的结构和功能作为突破点,探索卵巢癌中骨桥蛋白(OPN)的表达和功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号